Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

Zolgensma®▼ (onasemnogene abeparvovec) receives NICE final draft guidance in presymptomatic babies up to 12 months with spinal muscular atrophy (SMA)

March 16, 2023 Business Services

 London, UK, 16th March 2023 – Novartis Gene Therapies has confirmed that the National Institute for Health and Care Excellence …
News
Press release

Aldena Therapeutics Accelerates its Novel and Disruptive Approach to Immuno-Dermatology

March 16, 2023 Business Services

Boston, Massachusetts, March 16th, 2023 – Aldena Therapeutics Inc. (Aldena) a private biotech company pioneering siRNA-based therapies for dermatological indications, …
News
Press release

Optibrium and PostEra Collaborate to Integrate AI Drug Discovery Solutions

March 15, 2023 Business Services

 
News
Press release

DelSiTech Awarded a Grant to Develop Controlled and Sustained Release Injectables for Prophylactic HIV Vaccine

March 15, 2023 Business Services

Turku, Finland – March 15, 2023 – DelSiTech Ltd, a Finnish drug delivery and drug development company, today announces that …
News
Press release

HUTCHMED Announces Closing of Fruquintinib License to Takeda Outside China

March 14, 2023 Business Services

Hong Kong, Shanghai & Florham Park, NJ — Tuesday, March 14, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM, HKEX:​13) today announces that, further …
News
Press release

Synaffix Announces Expansion of ADC Collaboration with MacroGenics

March 14, 2023 Business Services

AMSTERDAM, NETHERLANDS, 14 March 2023, Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the …
News
Press release

Acesion Pharma announces positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint achieved

March 14, 2023 Business Services

14 March 2023, Copenhagen, Denmark – Acesion Pharma (“Acesion”), the biotech pioneering first-in-class novel therapies for Atrial Fibrillation (“AF”), the …
News
Press release

EP0042 receives Orphan Drug Designation from the US Food and Drug Administration

March 14, 2023 Business Services

 Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an …
News
Press release

Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases

March 14, 2023 Business Services

Aarhus, Denmark March 14th, 2023: Teitur Trophics (“Teitur”), a biotech company dedicated to developing new treatments for patients suffering from …
News
Press release

Newron announces 2022 financial results and provides outlook for 2023

March 14, 2023 Business Services

Milan, Italy, March 14, 2023, 7 am CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company …
News
Press release

Cell and Gene Therapy Catapult opens new Process Analytical Technologies laboratory

March 14, 2023 Business Services

London, 14 March 2023: The Cell and Gene Therapy Catapult (CGT Catapult) today announces the opening of a new laboratory …
News
Press release

Scottish patients with the most aggressive form of viral hepatitis become first in UK to be offered routine NHS access to Hepcludex® (bulevirtide)

March 14, 2023 Business Services

Monday 13 March 2023, London, UK – Gilead Sciences Ltd today announced that the Scottish Medicines Consortium (SMC) has become …
News
Press release

Cingulate and Indegene Announce Joint Commercialization Agreement for Lead ADHD Candidate CTx-1301

March 13, 2023 Business Services

KANSAS CITY, KANSAS and PRINCETON, NEW JERSEY – March 13, 2023 – Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing …
News
Press release

BRITISH LAND AND AUSTRALIANSUPER ANNOUNCE LIFE SCIENCES AMBITION AT CANADA WATER

March 13, 2023 Business Services

13 March 2023
News
Press release

Calliditas Announces Primary Endpoint Successfully Met in Phase 3 NefIgArd Trial Evaluating Nefecon® in IgA Nephropathy

March 13, 2023 Business Services

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced positive topline results from the global, randomized, double-blind, placebo-controlled …
News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025